CFR PHARMACEUTICALS SA |
End-of-day quote
Other stock markets
|
||
| - CLP | - |
|
| 2014 | Abbott Laboratories : to buy Latin American drugmaker CFR in $2.9 billion deal | RE |
| 2014 | AbbVie : Abbott to buy Latin American drugmaker CFR in $2.9 billion deal | RE |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 8,416,000,000 | 33,664,000 ( 0.4000 %) | 0 | 0.4000 % |
Company contact information
CFR Pharmaceuticals SA
Avenida Pedro de Valdivia No. 295 Providencia
7500524, Santiago
+
http://www.cfr-corp.com
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| +24.53% | 45.07B | |
| +30.99% | 23.39B | |
| +24.13% | 16.08B | |
| +21.15% | 14.6B | |
| +68.67% | 14.01B | |
| -0.05% | 6.79B | |
| -13.29% | 6.38B | |
| -8.87% | 5.73B | |
| +13.53% | 5.64B |
- Stock Market
- Equities
- CFR Stock
- Company CFR Pharmaceuticals SA
